C. Fox

First name

C.

Middle name

P.

Last name

Fox

Abhishek, A., Grainge, M., Card, T., Williams, H. C., Taal, M. W., Aithal, G. P., et al. (2024). Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation. Rmd Open, 10. http://doi.org/10.1136/rmdopen-2023-003980

View

Nakafero, G., Card, T., Grainge, M. J., Williams, H. C., Taal, M. W., Aithal, G. P., et al. (2023). Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation. Eclinicalmedicine, 64, 102213. http://doi.org/10.1016/j.eclinm.2023.102213

View

Nakafero, G., Grainge, M. J., Williams, H. C., Card, T., Taal, M. W., Aithal, G. P., et al. (2023). Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK. Bmj, 381, e074678. http://doi.org/10.1136/bmj-2022-074678

View

Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Riley, R., van der Windt, D., et al. (2022). Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum. Rheumatol Adv Pract, 6, rkac046. http://doi.org/10.1093/rap/rkac046

View

Nakafero, G., Grainge, M. J., Card, T., Taal, M. W., Aithal, G. P., Zhang, W., et al. (2021). Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood-tests during long-term treatment: cohort study using data from Clinical Practice Research Datalink Gold and Aurum. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keab790

View